Duke Clinical Research Institute
- Advisory Board: Alkermes, Inc. ; Attention Therapeutics, Inc.; Avanir Pharmaceuticals, Inc.; Eli Lilly and Company; Pfizer Inc; Scion Pharmaceuticals, Inc.; Translational Venture Partners, LLC; VIVUS, Inc.
- Consultant: Eli Lilly and Company; Johnson & Johnson; Pfizer Inc
- Research Support: Pfizer Inc
- Royalties: Guilford Press ; Multi-Health Systems Inc.; Oxford University Press
- Stock or Equity: MedAvante, Inc.